Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Ticlopidine Continues to Cause Serious ADRs: Korosho
July 30, 2001
- FALCO biosystems to Take Over Lab Test Business from Subsidiary
July 30, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF -1-
July 30, 2001
- Checklist Issued for Clinical Trials of Medical Devices
July 30, 2001
- JMA, JDA, JPA Join Hands to Oppose Government's Reform Proposals
July 30, 2001
- Shimadzu: HPLC Autosampler SIL-HT
July 30, 2001
- Asahi Glass Ties Up with DMS Biologics to Contract to Manufacture Biotechnology Drugs
July 30, 2001
- Industry FTC to Prohibit Free Loan of Medical Devices
July 30, 2001
- Tanabe Licenses Bepotastine to Senju as Eye Drop
July 30, 2001
- Differences in Prices of Catheters in Japan, Abroad Highlighted: JSIC Meeting
July 30, 2001
- Makers Accelerating Business Restructuring
July 30, 2001
- WORLD NEWS IN BRIEF
July 30, 2001
- Drug Dispensing Cost Outstrips Dental Care Cost
July 30, 2001
- Pharmacia to Launch Nicorette as OTC Drug in Fall
July 23, 2001
- Shionogi Grants the Rights to BNP Assay to Bayer Corp.
July 23, 2001
- Tsuruha: Sales Up 19.5%, Net Profits Up 8.2%
July 23, 2001
- Oriental Yeast Expands Collaboration with Lexicon Genetics
July 23, 2001
- SSP Wants to Become No. 1 OTC Drug Maker
July 23, 2001
- Suzuken Aims to Become No.1 Wholesaler in 2010
July 23, 2001
- Boots-MC to Be Dissolved
July 23, 2001
ページ
Japan’s pharmaceutical industry could be on the verge of gaining a stronger voice in the Central Social Insurance Medical Council…
Let’s face it: in today’s world, changing jobs is a normal part of a successful career. But if it’s so normal, why does it feel so hard? For many people, the idea of leaving their current role brings a heavy…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…